These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29419409)

  • 1. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR; Tanratana P; Sheehan JP
    J Thromb Haemost; 2015 Jun; 13(6):1053-63. PubMed ID: 25851619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
    Buyue Y; Whinna HC; Sheehan JP
    Blood; 2008 Oct; 112(8):3234-41. PubMed ID: 18647957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa.
    Plautz WE; Chattopadhyay R; Goldfeld EI; Samelson-Jones BJ; Pilli VS; Campello E; Datta A; Arruda VR; Simioni P; Majumder R
    Thromb Res; 2018 Oct; 170():133-141. PubMed ID: 30189336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonasaccharide Inhibits Intrinsic Factor Xase Complex by Binding to Factor IXa and Disrupting Factor IXa-Factor VIIIa Interactions.
    Xiao C; Zhao L; Gao N; Wu M; Zhao J
    Thromb Haemost; 2019 May; 119(5):705-715. PubMed ID: 30900221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
    Neuenschwander PF
    Biochemistry; 2004 Mar; 43(10):2978-86. PubMed ID: 15005634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
    Misenheimer TM; Buyue Y; Sheehan JP
    Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.
    Vadivel K; Schreuder HA; Liesum A; Schmidt AE; Goldsmith G; Bajaj SP
    J Thromb Haemost; 2019 Apr; 17(4):574-584. PubMed ID: 30725510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis.
    Kao CY; Lin CN; Yu IS; Tao MH; Wu HL; Shi GY; Yang YL; Kao JT; Lin SW
    Thromb Haemost; 2010 Aug; 104(2):355-65. PubMed ID: 20539913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein S antibody as an adjunct therapy for hemophilia B.
    Wilson HP; Pierre A; Paysse AL; Kumar N; Cooley BC; Rudra P; Dorsey AW; Polania-Villanueva D; Chatterjee S; Janbain M; Velez MC; Majumder R
    Blood Adv; 2024 Jan; 8(2):441-452. PubMed ID: 37773781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.
    Johnson DJ; Langdown J; Huntington JA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):645-50. PubMed ID: 20080729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the heparin binding exosite of factor IXa.
    Yang L; Manithody C; Rezaie AR
    J Biol Chem; 2002 Dec; 277(52):50756-60. PubMed ID: 12397068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of factor IXa by supersulfated low molecular weight heparin.
    Misenheimer TM; Sheehan JP
    Biochemistry; 2010 Nov; 49(46):9997-10005. PubMed ID: 20945941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.
    Ogawa S; Szlam F; Dunn AL; Bolliger D; Ohnishi T; Hosokawa K; Tanaka KA
    Haemophilia; 2012 Nov; 18(6):926-32. PubMed ID: 22642581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.
    Ivanciu L; Arruda VR; Camire RM
    Blood; 2023 Apr; 141(16):2022-2032. PubMed ID: 36724452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
    Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.